Southern Research Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Southern Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7544
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Southern Research Institute (Southern Research) is an independent, non-profit, and scientific research organization that conducts research in the areas of preclinical drug development, advanced engineering, drug discovery, environmental protection, and others. The organization offers life science services such as preclinical drug development, lead discovery and optimization, preclinical drug development, basic research and target identification, and clinical trial support services for pharmaceutical and biotechnology companies, among others. It also provides engineering services in the areas of airborne sensor design, fabrication and integration; advanced materials and structures; and systems engineering and integration, among others. Southern Research offers its services to energy sector such as technology development, field verification and testing, and technology consulting services. The organization offers services to life sciences, energy, engineering and environmental protection industries. Southern Research is headquartered in Birmingham, Alabama, the US.

Southern Research Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Southern Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Southern Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Southern Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Southern Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Southern Research Institute, Medical Devices Deals, 2012 to YTD 2018 9
Southern Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Southern Research Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Southern Research Enters into Agreement with University of Tennessee 11
Cyclenium Pharma Announces Drug Discovery And Development Agreement With Southern Research Institute 12
Southern Research Institute Enters into Collaboration Agreement with UTMB Health 13
Licensing Agreements 14
Bionetix and Southern Research Enter into Licensing Agreement 14
Southern Research Institute – Key Competitors 15
Southern Research Institute – Key Employees 16
Southern Research Institute – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Southern Research Institute, Pharmaceuticals & Healthcare, Key Facts 2
Southern Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Southern Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Southern Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Southern Research Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Southern Research Institute, Medical Devices Deals, 2012 to YTD 2018 9
Southern Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Southern Research Enters into Agreement with University of Tennessee 11
Cyclenium Pharma Announces Drug Discovery And Development Agreement With Southern Research Institute 12
Southern Research Institute Enters into Collaboration Agreement with UTMB Health 13
Bionetix and Southern Research Enter into Licensing Agreement 14
Southern Research Institute, Key Competitors 15
Southern Research Institute, Key Employees 16
Southern Research Institute, Other Locations 18

List of Figures
Southern Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Southern Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Southern Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Southern Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Southern Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Southern Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Southern Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Southern Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Southern Research Institute, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Southern Research Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Akorn Inc (AKRX)-製薬・医療分野:企業M&A・提携分析
    Summary Akorn Inc (Akorn) is a pharmaceutical company which carries out the development, manufacturing and commercialization of generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health pharmaceuticals. The company offers its product …
  • YPF SA:企業のM&A・事業提携・投資動向
    YPF SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's YPF SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital rais …
  • University of Leeds:医療機器:M&Aディール及び事業提携情報
    Summary University of Leeds (University of Leeds) is an educational university that offers academic programs. The university offers undergraduate, post graduate, research degrees, online and distance learning educational programs. It offers education programs in the areas of arts, biological science …
  • Nordic Investment Bank:電力:M&Aディール及び事業提携情報
    Summary Nordic Investment Bank (NIB) is a banking and financial service provider that offers loans and capital market solutions. The company offers loan products such as project and structured loans, corporate loans, municipality’s loans, environmental loans, sovereign loans, and other loans. It als …
  • Camurus AB (CAMX):企業の財務・戦略的SWOT分析
    Summary Camurus AB (Camurus), a subsidiary of Sandberg Development AB, is a pharmaceutical company that carries out development and commercialization of treatments for the patients suffering from chronic diseases. The company’s technology includes smart and versatile drug delivery, injection depot, …
  • AMEWAS, Inc.:企業の戦略・SWOT・財務分析
    AMEWAS, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMEWAS, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)-医療機器分野:企業M&A・提携分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • eGain Corp (EGAN):企業の財務・戦略的SWOT分析
    Summary eGain Corp (eGain) is a technology company that provides cloud-based and on-site customer engagement software solutions. The company offers products such as eGain case manager, eGain chat, eGain clicktocall, eGain cobrowse, eGain community, eGain consulting, and eGain virtual assistant. It a …
  • TransUnion LLC:企業の戦略・SWOT・財務分析
    TransUnion LLC - Strategy, SWOT and Corporate Finance Report Summary TransUnion LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Oltchim SA (OLT):企業の財務・戦略的SWOT分析
    Summary Oltchim SA (Oltchim) is a chemical company that manufactures and markets petrochemical products. The company offers inorganic, macro molecular and organic synthesis products. Its inorganic products include caustic soda, liquid chlorine, hydrochloric acid and sodium hypochlorite. Oltchim's ma …
  • Timberland LLC:戦略・SWOT・企業財務分析
    Timberland LLC - Strategy, SWOT and Corporate Finance Report Summary Timberland LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Liechtensteinische Landesbank Ag
    Liechtensteinische Landesbank Ag - Strategy, SWOT and Corporate Finance Report Summary Liechtensteinische Landesbank Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Ajinomoto Co Inc (2802):企業の財務・戦略的SWOT分析
    Ajinomoto Co Inc (2802) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ornim Inc-医療機器分野:企業M&A・提携分析
    Summary Ornim Inc (Ornim) is a medical device company that specializes in clinical research, development, and distribution of medical devices in the field of tissue and cerebral blood flow and perfusion. The company’s c-FLOW is a continuous non-invasive monitor of deep tissue blood flow that is used …
  • Neviot Nature of Galilee Ltd.:企業の戦略・SWOT・財務分析
    Neviot Nature of Galilee Ltd. - Strategy, SWOT and Corporate Finance Report Summary Neviot Nature of Galilee Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Ivy Cosmetics Corporation:企業の戦略・SWOT・財務分析
    Ivy Cosmetics Corporation - Strategy, SWOT and Corporate Finance Report Summary Ivy Cosmetics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Toppan Forms Co Ltd
    Toppan Forms Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Toppan Forms Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Laboratorio Reig Jofre SA (RJF):製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorio Reig Jofre SA (Reig Jofre) is a pharmaceutical company that researches, develops, manufactures and markets medicinal products and nutritional supplements. The company’s product categories include specialized technology products, specialty therapeutic areas, and consumer healthcar …
  • Centric Health Corporation:企業のM&A・事業提携・投資動向
    Centric Health Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Centric Health Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Industriens Pensionsforsikring AS:電力:M&Aディール及び事業提携情報
    Summary Industriens Pensionsforsikring AS (Industriens Pensionsforsikring) is an insurance service provider. The company offers member pension insurance and company pension insurance products. Its member pension insurance covers critical illness, loss of earning capacity, death, healthcare, insuranc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆